ConductScience.org, home

Comparison · NCT04343521-deaths

Targeted Indoor Residual Spraying (TIRS) vs Routine Aedes-borne Virus (ABV) Prevention and Control: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Targeted Indoor Residual Spraying (TIRS) vs Routine Aedes-borne Virus (ABV) Prevention and Control: deaths from any cause. Trial comparisons, record NCT04343521-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04343521-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.0004470.00007880.00253wilson
Risk in group 20.00090.0002470.00328wilson
Risk difference, group 1 minus group 2-0.000453-0.002860.00173newcombe hybrid score
Risk ratio, group 1 over group 20.4960.0455.47log
Odds ratio, group 1 over group 20.4960.04495.47log
Number needed to treat, for one fewer death from any cause on Targeted Indoor Residual Spraying (TIRS) than on Routine Aedes-borne Virus (ABV) Prevention and Control2,210from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Targeted Indoor Residual Spraying (TIRS)Children residing in households located in Targeted Indoor Residual Spraying (TIRS) clusters that were offered the intervention.12,239EG000
Group 2Routine Aedes-borne Virus (ABV) Prevention and ControlChildren residing in households located in routine Aedes-borne virus (ABV) prevention and control clusters, without Targeted Indoor Residual Spraying (TIRS).22,222EG001

Harm

What it counts
Total, all-cause mortality
Time frame
Information on adverse events was collected beginning at the time when individuals gave consent to participate in the study and continued through the final assessment (up to 41 months and 26 days).

Source ClinicalTrials.gov

Trial

Title
Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases
NCT number
NCT04343521
Phases
NA
Conditions
Aedes-borne Diseases, Dengue, Chikungunya, Zika
Interventions
Targeted Indoor Residual Spraying (TIRS)
Lead sponsor
Emory University
Results first posted
2025-09-18

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04343521-deaths